Benzinga··PrnewswireSoligenix's SGX945 Earns UK Innovative Medicine Designation for Behçet's Disease
Soligenix's SGX945 earns UK Promising Innovative Medicine designation for Behçet's Disease, enabling early patient access with Phase 2 data showing 40% ulcer improvement.
SNGXrare diseaseBehçet's Disease